Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Uyttenhove, Catherine, Pilotte, Luc, Théate, Ivan, Stroobant, Vincent, Colau, Didier, Parmentier, Nicolas, Boon, Thierry, Van den Eynde, Benoît J·2003·Nature Medicine

DOI 10.1038/nm934

Cited by (1,003)

Items 701–800 of 1,003

Comprehensive Analysis of the Expressionand Prognosis for TDO2 in Breast Cancer
Qiang Liu, Jie Zhai, Xiangyi Kong, Xiangyu Wang, Zhongzhao Wang, Yi Fang, Jing Wang · 2020 · Molecular Therapy — Oncolytics
Identification and Characterization of a Novel Brain-Penetrant Indoleamine 2,3 Dioxygenase 1 Protein Degrader for Glioblastoma
Lakshmi Reddy Bollu, Prashant V. Bommi, Paige J. Monsen, Lijie Zhai, Kristen L. Lauing, April Bell, Miri Kim, Erik Ladomersky, Xinyu Yang, Leonidas C. Platanias et al. · 2022 · Journal of Medicinal Chemistry
Accurate Differentiation of Recurrent Gliomas from Radiation Injury by Kinetic Analysis of α-11C-Methyl-l-Tryptophan PET
Bálint Alkonyi, Geoffrey R. Barger, Sandeep Mittal, Otto Muzik, Diane C. Chugani, Gautam Bahl, Natasha L. Robinette, William J. Kupsky, Pulak K. Chakraborty, Csaba Juhász · 2012 · Journal of Nuclear Medicine
Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment
Alessandro Delli Poggi, Massimo Giuliani · 2016 · Vaccines
Breast Cancer Immunology and Immunotherapy
Luis de la Cruz‐Merino, M. Chiesa, Rosalía Caballero, Federico Rojo, Natalia Palazón Carrión, F.H. Carrasco, Víctor Sánchez‐Margalet · 2016 · International review of cytology
Recent discovery of indoleamine-2,3-dioxygenase 1 inhibitors targeting cancer immunotherapy
Tianwei Weng, Xiaqiu Qiu, Jubo Wang, Zhiyu Li, Jinlei Bian · 2017 · European Journal of Medicinal Chemistry
Development of Indoleamine 2,3-Dioxygenase 1 Inhibitors for Cancer Therapy and Beyond: A Recent Perspective
Xi Feng, Dongdong Liao, Dongyu Liu, An Ping, Zhiyu Li, Jinlei Bian · 2020 · Journal of Medicinal Chemistry
Peripheral T-Cell Tolerance Associated with Prostate Cancer Is Independent from CD4+CD25+ Regulatory T Cells
Elena Degl'Innocenti, Matteo Grioni, Giusy Capuano, Elena Jachetti, Massimo Freschi, Maria Teresa Sabrina Bertilaccio, Rodrigo Hess Michelini, Claudio Doglioni, Matteo Bellone · 2008 · Cancer Research
A phase 1 study of PF-06840003, an oral indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor in patients with recurrent malignant glioma
David A. Reardon, Annick Desjardins, Olivier Rixe, Timothy Francis Cloughesy, Shilpa Alekar, Jason H. Williams, Ray Li, Carrie Turich Taylor, Andrew B. Lassman · 2020 · Investigational New Drugs
Targeting tumor-infiltrating tregs for improved antitumor responses
Diyuan Qin, Yugu Zhang, Pei Shu, Yanna Lei, Xiaoyu Li, Yongsheng Wang · 2024 · Frontiers in Immunology
IL-1β Increases Expression of Tryptophan 2,3-dioxygenase and Stimulates Tryptophan Catabolism in Endometrioma Stromal Cells
Yoko Urata, Kaori Koga, Yasushi Hirota, Ikumi Akiyama, Gentaro Izumi, Masashi Takamura, Miwako Nagai, Miyuki Harada, Tetsuya Hirata, Osamu Yoshino et al. · 2014 · American Journal of Reproductive Immunology
Control of the Antitumor Immune Response by Cancer Metabolism
Charlotte Domblides, Lydia Lartigue, Benjamin Faustin · 2019 · Cells
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis—Masters of Survival and Clonality?
Lisa Pleyer, Peter Valent, Richard Greil · 2016 · International Journal of Molecular Sciences
Tryptophan 2,3-Dioxygenase Expression Identified in Human Hepatocellular Carcinoma Cells and in Intratumoral Pericytes of Most Cancers
Delia Hoffmann, Tereza Dvořáková, Vincent Stroobant, Caroline Bouzin, Aurélie Daumerie, Marie Solvay, Simon Klaessens, Marie-Claire Letellier, Jean‐Christophe Renauld, Nicolas van Baren et al. · 2019 · Cancer Immunology Research
Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment
Zhou Jiang, Jennifer L. Hsu, Yintao Li, Gabriel N. Hortobágyi, Mien‐Chie Hung · 2020 · Frontiers in Oncology
Chromatin accessibility governs the differential response of cancer and T cells to arginine starvation
Nicholas T. Crump, Andreas V. Hadjinicolaou, Xia Meng, John Walsby-Tickle, Uzi Gileadi, Ji‐Li Chen, Mashiko Setshedi, Lars Rønn Olsen, I‐Jun Lau, Laura Godfrey et al. · 2021 · Cell Reports
Tumor antigen-targeting monoclonal antibody-based immunotherapy: Orchestrating combined strategies for the development of long-term antitumor immunity
Henri‐Alexandre Michaud, Jean‐François Eliaou, Virginie Lafont, Nathalie Bonnefoy, Laurent Gros · 2014 · OncoImmunology
Immunosuppressive mechanisms in human tumors: Why we still cannot cure cancer
Stefanie Groß, Peter Walden · 2007 · Immunology Letters
Pre-treatment effects of peripheral tumors on brain and behavior: Neuroinflammatory mechanisms in humans and rodents
Andrew Schrepf, Susan K. Lutgendorf, Leah M. Pyter · 2015 · Brain Behavior and Immunity
Development of simultaneous analysis of tryptophan metabolites in serum and gastric juice – an investigation towards establishing a biomarker test for gastric cancer diagnosis
Jong Min Choi, Won Sang Park, Kyo Young Song, Hwa Jeong Lee, Byung Hwa Jung · 2016 · Biomedical Chromatography
Multimodal imaging-defined subregions in newly diagnosed glioblastoma: impact on overall survival
Flóra John, Edit Bosnyák, Natasha L. Robinette, Alit J Amit-Yousif, Geoffrey R. Barger, Keval Shah, Sharon K. Michelhaugh, Neil V. Klinger, Sandeep Mittal, Csaba Juhász · 2018 · Neuro-Oncology
The complex relationship between MITF and the immune system: a Melanoma ImmunoTherapy (response) Factor?
Robert Ballotti, Yann Chéli, Corine Bertolotto · 2020 · Molecular Cancer
Mechanisms of tumor escape: role of tumor microenvironment in inducing apoptosis of cytolytic effector cells
Alessandro Delli Poggi, Maria Raffaella Zocchi · 2006 · Archivum Immunologiae et Therapiae Experimentalis
Extracellular vimentin modulates human dendritic cell activation
Mary Beth Yu, Joshua Guerra, Anthony Francis Firek, William H. R. Langridge · 2018 · Molecular Immunology
A review of fasting effects on the response of cancer to chemotherapy
Mehdi Sadeghian, Sepideh Rahmani, Saman Khalesi, Ehsan Hejazi · 2020 · Clinical Nutrition
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry
Teresa T. Nguyen, Dong Ho Shin, Sagar Shashikant Sohoni, Sanjay Kumar Singh, Yisel A. Rivera-Molina, Hong Jiang, Xuejun Fan, Joy Gumin, Frederick F. Lang, Christopher A Alvarez-Breckenridge et al. · 2022 · Journal for ImmunoTherapy of Cancer
The role of indoleamine 2,3-dioxygenase in transplantation
Ursula Hainz, Birgit Jürgens, Andreas Heitger · 2006 · Transplant International
Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation
Bobby J. Cherayil · 2009 · Inflammatory Bowel Diseases
Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway
Martina Ott, Ulrike M. Litzenburger, Katharina J. Rauschenbach, Lukas Bunse, Katharina Ochs, Felix Sahm, Stefan Pusch, Christiane A. Opitz, Jonas Blaes, Andreas von Deimling et al. · 2014 · Glia
IDO1 Plays an Immunosuppressive Role in 2,4,6-Trinitrobenzene Sulfate–Induced Colitis in Mice
Manabu Takamatsu, Akihiro Hirata, Hirofumi Ohtaki, Masato Hoshi, Yuichiro Hatano, Hiroyuki Tomita, Toshiya Kuno, Kuniaki Saito, Akira Hara · 2013 · The Journal of Immunology
Immunomodulation of Curcumin on Adoptive Therapy with T Cell Functional Imaging in Mice
Ya-Fang Chang, Hui‐Yen Chuang, Chien-Hui Hsu, Ren-Shyan Liu, Sanjiv Sam Gambhir, Jeng‐Jong Hwang · 2011 · Cancer Prevention Research
Somatic mutation, copy number and transcriptomic profiles of primary and matched metastatic estrogen receptor-positive breast cancers
Debora Fumagalli, Timothy Richard Wilson, Roberto Salgado, Xuyang Lu, Jianjun Yu, Carol Lynn O'Brien, K. Walter, L Huw, Carmen Criscitiello, I. Laïos et al. · 2016 · Annals of Oncology
Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation
Isabell Adam, Dyah Laksmi Dewi, Joram Mooiweer, Ahmed Sadik, Soumya R. Mohapatra, Bianca Berdel, Melanie Keil, Jana K. Sonner, Kathrin Thedieck, Adam J. Rose et al. · 2018 · OncoImmunology
PEG-Derivatized Dual-Functional Nanomicelles for Improved Cancer Therapy
Yanping Li, Ting Zhang, Qinhui Liu, Jinhan He · 2019 · Frontiers in Pharmacology
Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression
Benjamin Heng, AYSE AYSIN BOMBACI BILGIN, David B. Lovejoy, Vanessa X. Tan, Heloisa Helena Milioli, Laurence Gluch, Sonia Bustamante, Tharani Sabaretnam, Pablo Moscato, Chai K. Lim et al. · 2020 · Breast Cancer Research
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
Prashant Sharma, Mario Otto · 2023 · Bioactive Materials
Mobilizing the low-avidity T cell repertoire to kill tumors
Rachel H. McMahan, Jill E. Slansky · 2007 · Seminars in Cancer Biology
Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine
Vladislav Strmiska, Petr Michálek, Tomáš Eckschlager, Marie Stiborová, Vojtěch Adam, Soňa Křížková, Zbyněk Heger · 2019 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway
Fanni Annamária Boros, László Vécsei · 2019 · Frontiers in Immunology
Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model
Min-Jung Park, So‐Youn Min, Kyung-Su Park, Young Gyu Cho, Mi‐La Cho, Young‐Ok Jung, Hyun-Sil Park, Soog-Hee Chang, Seok‐Goo Cho, Jun‐Ki Min et al. · 2008 · Arthritis Research & Therapy
Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
Steven Zhao, Ronal M. Peralta, Natalia Avina-Ochoa, Greg M. Delgoffe, Susan M. Kaech · 2021 · Seminars in Immunology
Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review
Lucía Serrano-García, Beatriz Jávega, Antonio Llombart‐Cussac, María Gión, José Manuel Pérez-García, Javier Cortés, María Leonor Fernández-Murga · 2024 · Frontiers in Immunology
Inhibitors of human indoleamine 2,3‐dioxygenase identified with a target‐based screen in yeast
Eduardo Vottero, Aruna D. Balgi, Kate Woods, Stuart Tugendreich, Teri Mélèse, Raymond J. Andersen, A. Grant Mauk, Michel Roberge · 2006 · Biotechnology Journal
1-l-methyltryptophan is a more effective inhibitor of vertebrate IDO2 enzymes than 1-d-methyltryptophan
Hajime Julie Yuasa, Helen J. Ball, Christopher Austin, Nicholas Henry Hunt · 2010 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection
Julie M. Fox, Leo K. Sage, Lei Huang, James P. Barber, Kimberly D. Klonowski, Andrew L. Mellor, Stephen Mark Tompkins, Ralph A. Tripp · 2013 · Journal of General Virology
Immune-refractory cancers and their little helpers—An extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
Jörg Wischhusen, Anne Waschbisch, Heinz Wiendl · 2007 · Seminars in Cancer Biology
Indoleamine 2,3-Dioxygenase (IDO)
Marina Scheler, Joerg Wenzel, Thomas Tüting, Osamu Takikawa, Thomas R.M. Bieber, Dagmar von Bubnoff · 2007 · American Journal Of Pathology
Emerging Targets in Cancer Immunotherapy: Beyond CTLA-4 and PD-1
Amer Assal, Justin D. Kaner, Gopichand Pendurti, Xingxing Zang · 2015 · Immunotherapy
Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells
Elina Timosenko, Hemza Ghadbane, Jonathan D. Silk, Dawn Shepherd, Uzi Gileadi, Lauren J. Howson, Robert Laynes, Qi Zhao, Robert L. Strausberg, Lars Rønn Olsen et al. · 2016 · Cancer Research
Detection of Epstein-Barr Virus Infection in Non-Small Cell Lung Cancer
Fayez M. Kheir, Mengmeng Zhao, Michael J. Strong, Yi Yu, Asuka Nanbo, Erik K. Flemington, Gilbert F. Morris, Krzysztof Reiss F, Li Li, Zhen Nan Lin · 2019 · Cancers
Low Levels of Serum Tryptophan Underlie Skeletal Muscle Atrophy
Soranobu Ninomiya, Nobuhiko Nakamura, Hiroshi Nakamura, Taku Mizutani, Yuto Kaneda, Kimihiro Yamaguchi, Takuro Matsumoto, Junichi Kitagawa, Nobuhiro Kanemura, Makoto Shiraki et al. · 2020 · Nutrients
Targeting tumour-associated macrophages
Antonio Sica, Luca Rubino, Alessandra Mancino, Paola Larghi, Chiara Porta, Monica Rimoldi, Graziella Solinas, Massimo Locati, Paola Allavena, Alberto Mantovani · 2007 · Expert Opinion on Therapeutic Targets
Diverse Physiological Roles of Kynurenine Pathway Metabolites: Updated Implications for Health and Disease
Yue-Chan Wang, Yong-Gang Zhang, Wei Wang, Yan-Min Zhang, Xue-Qian Dong, Yang Liu · 2025 · Metabolites
Tumor-infiltrating lymphocytes: apparently good for melanoma patients. But why?
Arcadi Cipponi, Grégoire Wieërs, Nicolas van Baren, Pierre G. Coulie · 2011 · Cancer Immunology Immunotherapy
T-Cell Tolerance in Cancer
Roza Nurieva, Junmei Wang, Anupama Sahoo · 2013 · Immunotherapy
Discovery of Highly Potent Benzimidazole Derivatives as Indoleamine 2,3-Dioxygenase-1 (IDO1) Inhibitors: From Structure-Based Virtual Screening to in Vivo Pharmacodynamic Activity
M. Teresa Serafini, Enza Torre, Silvio Aprile, Erika Del Grosso, Alessandro Gesù, Alessia Griglio, Giorgia Colombo, Cristina Travelli, Salvatore Paiella, Annalisa Adamo et al. · 2020 · Journal of Medicinal Chemistry
Discovery and structure–activity relationships of phenyl benzenesulfonylhydrazides as novel indoleamine 2,3-dioxygenase inhibitors
Ming-Fu Cheng, Ming‐Shiu Hung, Jen‐Shin Song, Shu‐Yu Lin, Fang-Yu Liao, Mine-Hsine Wu, Wen‐Chi Hsiao, Chia‐Ling Hsieh, Jian‐Sung Wu, Yu‐Sheng Chao et al. · 2014 · Bioorganic & Medicinal Chemistry Letters
Metformin suppresses CYP1A1 and CYP1B1 expression in breast cancer cells by down-regulating aryl hydrocarbon receptor expression
Minh Truong, Hyung Gyun Kim, Thi Thu Phuong Tran, Tilak Khanal, Jae Ho Choi, Young‐Chul Chung, Tae Cheon Jeong, Hye Gwang Jeong · 2014 · Toxicology and Applied Pharmacology
Hepatitis C Virus Induces MDSCs-Like Monocytes through TLR2/PI3K/AKT/STAT3 Signaling
Naicui Zhai, Haijun Li, Hongxiao Song, Yang Yang, An Cui, Tianyang Li, Junqi Niu, Ian Nicholas Crispe, Lishan Su, Zhengkun Tu · 2017 · PLoS ONE
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma
Lijie Zhai, Erik Ladomersky, Carlos R. Dostal, Kristen L. Lauing, Kathleen Swoap, Leah K. Billingham, Galina Gritsina, Meijing Wu, Robert H. McCusker, David C. Binder et al. · 2017 · Brain Behavior and Immunity
Combination immunotherapy and radiation therapy strategies for pancreatic cancer—targeting multiple steps in the cancer immunity cycle
Snehal Gajiwala, Anna M. Torgeson, Ignacio Garrido‐Laguna, Conan Grant Kinsey, Shane A. J. Lloyd · 2018 · Journal of Gastrointestinal Oncology
Indoleamine Dioxygenase Inhibitors: Clinical Rationale and Current Development
Mayanne M. T. Zhu, Amanda R. Dancsok, Torsten O. Nielsen · 2019 · Current Oncology Reports
Pancreatic Cancer–Associated Depression
Adam F. Barnes, Theresa Pluth Yeo, Benjamin E. Leiby, Abigail L. Kay, Jordan Michael Winter · 2018 · Pancreas
Resistance Exercise Reduces Kynurenine Pathway Metabolites in Breast Cancer Patients Undergoing Radiotherapy
Philipp Zimmer, Martina E. Schmidt, Mirja Tamara Prentzell, Bianca Berdel, Joachim Wiskemann, Karl Heinz Kellner, Jürgen Debus, Cornelia M. Ulrich, Christiane A. Opitz, Karen Steindorf · 2019 · Frontiers in Oncology
Carbon-11: Radiochemistry and Target-Based PET Molecular Imaging Applications in Oncology, Cardiology, and Neurology
Sridhar Goud Nerella, Ahana Bhattacharya, Raman Kumar Joshi, Chandana Nagaraj, Rose Dawn Bharath, Pardeep Kumar · 2021 · Journal of Medicinal Chemistry
Indoleamine 2,3-dioxygenase promotes peritoneal dissemination of ovarian cancer through inhibition of natural killercell function and angiogenesis promotion
Saga · 2010 · International Journal of Oncology
Factors regulating apoptosis and homeostasis of CD4+CD25highFOXP3+ regulatory T cells are new therapeutic targets
Xiaofeng Yang · 2007 · Frontiers in bioscience
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
Andrea Botticelli, Silvia Mezi, Giulia Pomati, Bruna Cerbelli, Edoardo Cerbelli, Michela Roberto, Raffaele Giusti, Alessio Cortellini, Luana Lionetto, Simone Scagnoli et al. · 2020 · Frontiers in Immunology
What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
Yao Yu, Heng Liang, Xin Fang, Shengnan Zhang, Zikang Xing, Lei Shi, Chunxiang Kuang, Barbara Seliger, Qing Yang · 2021 · Journal of Experimental & Clinical Cancer Research
Advanced Biomaterials for Cell‐Specific Modulation and Restore of Cancer Immunotherapy
Shaobo Ruan, Yuanyu Huang, Mei He, Huile Gao · 2022 · Advanced Science
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies
Hamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ali Akbar Samadani, Mehryar Habibi Roudkenar · 2022 · Medical Oncology
Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
Klaus Laimer, Birgit Troster, Frank Rudolf Kloss, Georg Schäfer, Peter Obrist, Alexander Perathoner, Johannes Laimer, Gerald Brandacher, Michael Rasse, Raimund Margreiter et al. · 2011 · Oral Oncology
Novel indoleamine 2,3-dioxygenase-1 inhibitors from a multistep in silico screen
Jason R. Smith, Krystal J. Evans, Adam Wright, Robert D. Willows, Joanne F. Jamie, Renate Griffith · 2011 · Bioorganic & Medicinal Chemistry
Discovery and preliminary SARs of keto-indoles as novel indoleamine 2,3-dioxygenase (IDO) inhibitors
Eduard Dolušić, Pierre Larrieu, Sébastien Blanc, Frédéric Sapunaric, Jenny Pouyez, Laurence Moineaux, Delphine Colette, Vincent Stroobant, Luc Pilotte, Didier Colau et al. · 2011 · European Journal of Medicinal Chemistry
SOCS2-Induced Proteasome-Dependent TRAF6 Degradation: A Common Anti-Inflammatory Pathway for Control of Innate Immune Responses
Cortez McBerry, Rosa Maria Salazar Gonzalez, Nathaniel Shryock, Alexandra Dias, Júlio Aliberti · 2012 · PLoS ONE
Recent Advances in the Clinical Development of Immune Checkpoint Blockade Therapy for Mismatch Repair Proficient (pMMR)/non-MSI-H Metastatic Colorectal Cancer
James J. Lee, Edward Chu · 2018 · Clinical Colorectal Cancer
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
Matthias Läsche, Günter Emons, Carsten Gründker · 2020 · Frontiers in Oncology
Overexpression of Indoleamine 2,3-Dioxygenase in Human Endometrial Carcinoma Cells Induces Rapid Tumor Growth in a Mouse Xenograft Model
Norio Yoshida, Kazuhiko Ino, Yoshiyuki Ishida, Hiroaki Kajiyama, Eiko Yamamoto, Kiyosumi Shibata, Mikio Terauchi, Akihiro Nawa, Hidetoshi Akimoto, Osamu Takikawa et al. · 2008 · Clinical Cancer Research
α-Methyl- L -Tryptophan: Mechanisms for Tracer Localization of Epileptogenic Brain Regions
Diane C. Chugani · 2011 · Biomarkers in Medicine
Remodeling tumor immunosuppressive microenvironment via a novel bioactive nanovaccines potentiates the efficacy of cancer immunotherapy
Xiaoxue Xie, Yi Feng, Hanxi Zhang, Qingqing Su, Ting Song, Geng Yang, Tingting Li, Xiaodan Wei, Tingting Li, Xiang Qin et al. · 2022 · Bioactive Materials
PGE2-Induced IDO1 Inhibits the Capacity of Fully Mature DCs to Elicit anIn VitroAntileukemic Immune Response
Sara Trabanelli, Mariangela Lecciso, Valentina Salvestrini, Michèle Cavo, Darina Očadlíková, Roberto Massimo Lemoli, Antonio Curti · 2015 · Journal of Immunology Research
Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers
Barbara Sperner‐Unterweger, Gabriele Neurauter, Martin Klieber, Katharina Kurz, Verena Meraner, Alain Gustave Zeimet, Dietmar Fuchs · 2010 · Immunobiology
Endothelial Indoleamine 2,3-Dioxygenase Protects against Development of Pulmonary Hypertension
Yongguang Xiao, Helen A. Christou, Li Liu, Gary A. Visner, S. Alex Mitsialis, Stella Kourembanas, Hanzhong Liu · 2013 · American Journal of Respiratory and Critical Care Medicine
Diminished quality of life in patients with cancer correlates with tryptophan degradation
Katharina Schroecksnadel, Michael Fiegl, K. Prassl, Christiana Winkler, Hubert A. Denz, Dietmar Fuchs · 2007 · Journal of Cancer Research and Clinical Oncology
Tryptophan‐2,3‐dioxygenase is regulated by prostaglandin E2 in malignant glioma via a positive signaling loop involving prostaglandin E receptor‐4
Katharina Ochs, Martina Ott, Katharina J. Rauschenbach, Katrin Deumelandt, Felix Sahm, Christiane A. Opitz, Andreas von Deimling, Wolfgang Wick, Michael Platten · 2015 · Journal of Neurochemistry
Characterization of 2-Oxindole Forming Heme Enzyme MarE, Expanding the Functional Diversity of the Tryptophan Dioxygenase Superfamily
Yuyang Zhang, Yi Zou, Nelson L. Brock, Tingting Huang, Yingxia Lan, Xiaozheng Wang, Zixin Deng, Yi Tang, Shuangjun Lin · 2017 · Journal of the American Chemical Society
Dendritic cells and innate defense against tumor cells
Evelyn Ullrich, Cédric Menard, Caroline Flament, Magali Terme, Grégoire Mignot, Mathieu Bonmort, Joël Plumas, Laurence Chaperot, Nathalie Chaput, Laurence Zitvogel · 2008 · Cytokine & Growth Factor Reviews
Oncolytic viruses—immunotherapeutics on the rise
Brian A. Keller, John Cameron Bell · 2016 · Journal of Molecular Medicine
Current Status of Clinical Trials for Cervical and Uterine Cancer Using Immunotherapy Combined With Radiation
Brandon Alan Dyer, Christine H. Feng, Ramez Nassef Eskander, Andrew B. Sharabi, Loren K. Mell, Michael T McHale, Jyoti Mayadev · 2020 · International Journal of Radiation Oncology*Biology*Physics
Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer
Veronica Mariotti, Hyo Sook Han, Roohi R. Ismail-Khan, Shou‐Ching Tang, Patrick Michael Dillon, Alberto J. Montero, Andrew Stewart Poklepovic, Susan Anitra Melin, Nuhad K. Ibrahim, Eugene Paul Kennedy et al. · 2020 · JAMA Oncology
Tryptophan metabolism is inversely regulated in the tumor and blood of patients with glioblastoma
Verena Panitz, Saša Končarević, Ahmed Sadik, Dennis Friedel, Tobias Bausbacher, Saskia Trump, Vadim M. Farztdinov, Sandra Schulz, Philipp Sievers, S. Schmidt et al. · 2021 · Theranostics
The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions
Mario Preti, Elmar Armin Joura, Pedro Vieira‐Baptista, Marc van Beurden, Federica Bevilacqua, Maaike C.G. Bleeker, Jacob Bornstein, Xavier Carcopino, Cyrus Chargari, Margaret Eleanor Cruickshank et al. · 2022 · Journal of Lower Genital Tract Disease
Supramolecular Biomaterials for Cancer Immunotherapy
Huan Liang, Qingqing Lu, Jie Yang, Guocan Yu · 2023 · Research
Inhibition of indoleamine 2,3‐dioxygenase 1 expression alters immune response in colon tumor microenvironment in mice
Manabu Takamatsu, Akihiro Hirata, Hirofumi Ohtaki, Masato Hoshi, Tatsuya Ando, Hiroyasu Ito, Yuichiro Hatano, Hiroyuki Tomita, Toshiya Kuno, Kuniaki Saito et al. · 2015 · Cancer Science
Model of Tryptophan Metabolism, Readily Scalable Using Tissue-specific Gene Expression Data
Anne-Kristin Stavrum, Ines Heiland, Stefan Schuster, Pål Puntervoll, Mathias Ziegler · 2013 · Journal of Biological Chemistry
Organ transplant recipients with Merkel cell carcinoma have reduced progression-free, overall, and disease-specific survival independent of stage at presentation
Sarah T. Arron, Theresa N. Canavan, Siegrid S. Yu · 2014 · Journal of the American Academy of Dermatology
In vitro activated human T lymphocytes very efficiently attach to allogenic multipotent mesenchymal stromal cells and transmigrate under them
Domizio Suvà, Jakob Robert Passweg, Serge Arnaudeau, Pierre J Hoffmeyer, Vincent Kindler · 2007 · Journal of Cellular Physiology
Novel immunotherapies for hematologic malignancies
Michelle Hase Nelson, Chrystal Mary Paulos · 2014 · Immunological Reviews
Immunological challenges for peptide-based immunotherapy in glioblastoma
Malte Mohme, Marian Christoph Neidert, Luca Regli, Michael Weller, Roland Martinꝉ · 2013 · Cancer Treatment Reviews
Differentiation of Glioblastomas from Metastatic Brain Tumors by Tryptophan Uptake and Kinetic Analysis: A Positron Emission Tomographic Study with Magnetic Resonance Imaging Comparison
David Olayinka. Kamson, Sandeep Mittal, Amy Buth, Otto Muzik, William J. Kupsky, Natasha L. Robinette, Geoffrey R. Barger, Csaba Juhász · 2013 · Molecular Imaging